1. Jack Nathan Medical Corp. reports significant financial shifts for Q1 fiscal 2026. 2. Closure of Mexico operations aims to focus solely on Canadian MedSpa business. 3. Total revenue decreased by 14% to $412,791 in the first half of 2025. 4. The company aims to achieve breakeven by year-end through cost restructuring. 5. Cash reserves have decreased significantly from $2.2M to $0.8M.
The 14% revenue decline and reduced cash reserves raise concerns about financial stability.
Financial struggles and operational shifts could lead to investor concerns and impact stock price.
Current financial deficiencies may affect stock price in the near future, similar to past decreased revenues.
Jack Nathan Medical Corp. (TSXV:JNH, OTCID: JNHMF)) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
Management Commentary
Mike Marchelletta, Chief Executive Officer, commented:
"Q2 marked the closure of our Mexico operations and the start of the wind-down process of our Mexico subsidiary. This allows us to focus entirely on our Canadian MedSpa business, as well explore new growth opportunities, where cost restructuring has created a lean model. We are already seeing improved adjusted EBITDA and remain confident in reaching breakeven by year-end."
Financial Highlights for the three and six months ended July 31, 2025
Operating Results
Three months ended July 31 |
Six months ended July 31 |
|||||||
2025
|
2024
|
2025
|
2024
|
|||||
| Revenues | 227,532 |
264,546 |
412,791 |
471,548 |
||||
| Operating expenses | (709,698) |
(1,088,630) |
(1,352,491) |
(2,123,836) |
||||
| Loss from continuing operations | (482,166) |
(824,084) |
(939,700) |
(1,652,288) |
||||
For the six months ended July 31, 2025, total revenues from continuing MedSpa operation was $412,791 (2024 - $471,548), a decrease of $37,014 or 14%. As of July 31, 2025, the Company operated four MedSpa clinics in Alberta and Ontario. MedSpa revenue decreased by $58,757 or 12% during the six months ended July 31, 2025 compared to the same period in 2024.
Note on Mexico Operations:
The Q2 2026 financial statements reflect the Mexico operations as discontinued operations, as all clinics were closed as of June 30, 2025 following the termination of the Company's agreement with Walmart Mexico. The Company is currently in the process of winding down the Mexico subsidiary, including recovery of accounts receivable and settlement of severance and other liabilities. Going forward, the Mexico division will no longer form part of Jack Nathan Health's active business.
Balance Sheet as of July 31, 2025
Shares Outstanding
As of July 31, 2025, the Company had 87,099,159 common shares outstanding, 1,300,000 stock options outstanding and 335,004 DSUs outstanding.
For further information regarding the Company's financial results for fiscal year ended January 31, 2025, please refer to the audited annual consolidated financial statements of the Company as at and for the 12 months ended January 31, 2025 together with the corresponding MD&A, available at www.sedarplus.ca and the JNH website https://investors.jnhmexico.com.
About Jack Nathan Medical Corp.
Jack Nathan Health® is a provider of MedSpa services in Canada and a former operator of one of the largest retail medical clinic networks in North America. Established in 2006 the Company expanded its international footprint, delivering exceptional, state-of-the-art, turn-key medical centers in 253 locations globally, with 193 corporately owned and operated. In Canada, the Company grew to 82 locations, including 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and 2 independent locations, with 22 corporate owned and operated clinics of which 3 included Rehab services and 6 included MedSpa services. In Mexico, the Company grew to 171 corporate owned clinics across Mexico within 3 divisions, including 165 retail clinics, 5 clinics inside Walmart Distribution Centers servicing Walmart Associates, and 1 multidisciplinary clinic. In December 2024, Jack Nathan Health restructured its Canadian medical operations through an asset sale to Well Health Technologies Corp and ceased its operation in Walmart Mexico in June 2025. Following the exit from its Walmart Mexico operations, the Company continues to operate its Canadian MedSpa clinics.
For more information, visit https://investors.jnhmexico.com or www.sedarplus.ca.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Appendix:
Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to Jack Nathan are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to them, and are subject to certain risks, uncertainties, and assumptions Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Such factors include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative and other judicial, regulatory, political, and competitive developments; and operational difficulties. This list is not exhaustive of the factors that may affect forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.
Source: Jack Nathan Medical Corp.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250929747123/en/
Jack Nathan Medical Corp., Mike Marchelletta, Chief Executive Officer, (647)-488-5008